Navigation Links
Aridol in Medical News

Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)

...n important underlying component of asthma." aridol will be a standardized test kit containing proprie...sing a proprietary hand-held inhaler. The goal of aridol is to provide physicians and health care professio...d Stephen Beckman, President, Pharmaxis, Inc. aridol is approved for sale in Australia, major European ...

Pharmaxis to Expand Manufacturing Capacity

...iratory and immune disorders. Its development pipeline of products include: aridol for the management of asthma, Bronchitol for cystic fibrosis, bronchiectasi...initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media re...
Aridol in Medical Technology

Pharmaxis Reports Phase II Results for Aridol in COPD

SYDNEY, Australia, March 14, 2007 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis today announced the results from its Phase II trial for Aridol in subjects with Chronic Obstructive Pulmonary Disease (COPD), a respiratory disease affecting over 30 million people worldwide. The ...

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

...iratory and immune disorders. Its development pipeline of products includes aridol for the diagnosis of asthma, Bronchitol for cystic fibrosis, bronchiectasis...initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media re...

Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Announces New Drug Application Submission for Aridol(TM)

...ternational randomized pivotal Phase 3 trials with aridol involving over 1,000 subjects. The NDA applic...bronchial challenge test available in the U.S. and aridol is the first test of this kind that comes complete...s a substantial impact on the health of a nation. aridol was developed to assist with improving existing ma...

ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Bronchitol Cystic Fibrosis Dose Trial Results Positive

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...
Aridol in Biological Technology

Pharmaxis Aridol Approved for Sale in Switzerland

SYDNEY, Australia, Oct. 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that it had received approval to market Aridol from the Swiss therapeutic regulatory agency Swissmedic. Aridol is indicated for measuring airway hyperresponsi...

Pharmaxis' Aridol Authorised for Sale in Germany

SYDNEY, Australia, May 18 /Xinhua-PRnewswire-Firstcall/ -- Specialist Pharmaceutical Company Pharmaxis Ltd (ASX: PXS; Nasdaq: PXSL) today announced that it has received national approval to market Aridol in Germany. Aridol is indicated for measuring airway hyperresponsiveness and has been ap...

Pharmaxis' Aridol Gains First Asian Approval

SYDNEY, Jan. 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the Korean regulatory agency has granted marketing approval for its asthma management product, Aridol. "This is the first Asian approval of Aridol," said Pharmaxis Chief Executive Officer Dr A...

Pharmaxis Appoints Portuguese Distributor for Aridol

SYDNEY, Australia, Dec. 14 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of Pulmocor SA to market and distribute its asthma diagnostic tool, Aridol in Portugal. "Portugal was one of the 13 European countries included in the successful mut...

Pharmaxis Closes Share Purchase Plan

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Announces Placement of $47 Million and Share Purchase Plan

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, an...

U.S. FDA Accepts Aridol(TM) New Drug Application for Review

...ber 2009. Pharmaxis is seeking approval for aridol for "the assessment of bronchial hyperresponsivene...ual economic cost of $19.7 billion. When approved, aridol will be the first dry powder bronchial challenge t...rking with the FDA to complete the review." aridol is approved for sale in most major European countr...

New Pharmaxis Board Appointment

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Appoints French Distributor for Aridol(TM)

...raxis on developing the French market for Aridol. aridol is a precisely engineered test that we believe will be an improvement on current practice. aridol improves the identification of bronchial hyperresp...ian that has previously not been available. aridol is approved for sale in most major European countr...
Other Tags
(Date:12/25/2014)... 26, 2014 “Every three months the trends ... A-line sweetheart evening dress will be one of the hottest ... of Yunx.co.uk says. Today, the company releases 26 A-line sweetheart ... to 80% off. , “We are trying our best ... with our latest designs. Along with affordable prices, we provide ...
(Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
(Date:12/25/2014)... 25, 2014 Recently, LunaDress.co.uk has updated its blog ... related accessories. Now, all of the models at LunaDress.co.uk come with ... groom lifts the wedding veil can turn out to be a ... A wedding veil can always bring surprise to a wedding. On ... how to choose veils for a big day . , ...
(Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
(Date:12/25/2014)... SmileStix ” was featured on NewsWatch as part of its ... on the iOS, Android, and Windows markets. Andrew Tropeano, a ... review and shared with viewers how this is an application ... goes, “A picture says a thousand words.” It’s true. There ... image, because each picture holds a unique and special meaning. ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ... its team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
Other Contents